Baird Financial Group, Inc. Dynavax Technologies Corp Call Options Transaction History
Baird Financial Group, Inc.
- $54.4 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DVAX
# of Institutions
295Shares Held
120MCall Options Held
294KPut Options Held
86.1K-
Black Rock Inc. New York, NY21.9MShares$223 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$181 Million6.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$85.9 Million0.0% of portfolio
-
State Street Corp Boston, MA6.4MShares$65.2 Million0.0% of portfolio
-
Chicago Capital, LLC4.31MShares$43.9 Million1.06% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.29B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...